Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Abrocitinib may effectively treat stubborn alopecia universalis.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

PCOS causes inflammation regardless of body weight.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Belatacept may be a promising treatment for alopecia areata.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Certain cytokines and growth factors can stop hair growth and may play a role in alopecia areata.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Dermal factors are crucial in regulating melanin production in skin.

Ginsenoside Rb1 may help remodel hypertrophic scars effectively at a dose of 0.56 mg.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Deucravacitinib helped a man regrow hair significantly.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

Double stranded RNA helps skin wounds heal by coordinating specific proteins and signaling pathways.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.